HLB PANAGENE Co., LTD.

A046210

KR7046210001

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
4,135 ^KRW	-0.84%		+1.35%	+0.12%

Jan. 25	Gencurix Inc. announced that it has received KRW 3.99999552 billion in funding from HLB PANAGENE Co., LTD.	CI
Jan. 24	HLB PANAGENE Co., LTD. announced that it has received KRW 2 billion in funding from Gencurix Inc.	CI

Panagene Inc.(KOSDAQ:A046210) added to S&P Global BMI Index

September 20, 2021 at 12:00 am EDT

Latest news about HLB PANAGENE Co., LTD.

Gencurix Inc. announced that it has received KRW 3.99999552 billion in funding from HLB PANAGENE Co., LTD.	Jan. 24	CI
HLB PANAGENE Co., LTD. announced that it has received KRW 2 billion in funding from Gencurix Inc.	Jan. 23	CI
HLB PANAGENE Co., LTD. announced that it expects to receive KRW 2 billion in funding from Gencurix Inc.	Jan. 16	CI
Gencurix Inc. announced that it expects to receive KRW 3.99999552 billion in funding from HLB PANAGENE Co., LTD.	Jan. 16	CI
Panagene to Raise 30 Billion Won From Shares Issuance; Shares Jump 30%	23-06-21	MT
Panagene Inc. announced that it expects to receive KRW 56.599994061 billion in funding from a group of investors	23-06-20	CI
Panagene Inc. announced that it expects to receive KRW 26.6 billion in funding from N Citron, Inc., Kukdong Corporation, Oruminc.Co.,Ltd, KR3 Co,. Ltd, and other investors	23-06-20	CI
Panagene Inc. announced that it expects to receive KRW 46.068324061 billion in funding from HLB Co., Ltd., HLB Investment Co., Ltd., HLB bioStep Co.,Ltd., HLB innoVation Co.,Ltd., HLB Therapeutics Co.,Ltd.	23-06-20	CI
Panagene Inc.(KOSDAQ:A046210) dropped from S&P Global BMI Index	22-09-19	CI
Panagene Inc.(KOSDAQ:A046210) added to S&P Global BMI Index	21-09-20	CI
Panagene Inc.(KOSDAQ:A046210) dropped from S&P Global BMI Index	21-03-22	CI
Panagene Inc.(KOSDAQ:A046210) added to S&P Global BMI Index	20-09-21	CI
Panagene Inc.(KOSDAQ:A046210) dropped from S&P Global BMI Index	19-09-23	CI
Panagene Inc.(KOSDAQ:A046210) added to S&P Global BMI Index	18-09-24	CI
Panagene Inc.(KOSDAQ:A046210) dropped from S&P Global BMI Index	17-09-18	CI
Panagene Inc.(KOSDAQ:A046210) added to S&P Global BMI Index	16-09-19	CI
Panagene Inc. announced that it has received KRW 14 million in funding.	14-03-24	CI
Panagene Inc. announced that it expects to receive KRW 14 billion in funding.	14-03-17	CI
PANAGENE Inc. Reports Earnings Results for the Year Ended Dec. 31, 2012	13-05-07	CI
PANAGENE Inc. Signs Off with Dako to Supply PNA Oligomer Component	13-02-22	CI

HLB PanaGene Co Ltd, formerly Panagene Inc, is a Korea-based company mainly engaged in the development of genetic diagnostic products. The Company operates its business through three segments. The Diagnostics Business segment mainly involves in manufacturing and sales of molecular diagnostic reagents, analysis services, and consumables. The Materials Business segment mainly engages in the manufacturing and sales of custom pentose nucleic acid (PNA) oligomers. The Nucleic Acid Extraction segment mainly engages in the manufacturing and sales of nucleic acid extraction equipment and extraction reagents.

Sector

Biotechnology & Medical Research

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
HLB PANAGENE CO., LTD.	+0.12%	124M
EXACT SCIENCES CORPORATION	-27.67%	9.87B
GUARDANT HEALTH, INC.	-17.30%	2.73B
BGI GENOMICS CO., LTD.	-11.15%	2.24B
VERACYTE, INC.	-22.32%	1.63B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+59.69%	1.39B
CAREDX, INC	+23.58%	771M
SEEGENE, INC.	-1.31%	760M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-28.57%	516M
CURIOX BIOSYSTEMS CO., LTD	+5.37%	310M

Bio Diagnostics & Testing

HLB PANAGENE Co., LTD.

Equities

A046210

KR7046210001

Biotechnology & Medical Research

Panagene Inc.(KOSDAQ:A046210) added to S&P Global BMI Index

Latest news about HLB PANAGENE Co., LTD.

Chart HLB PANAGENE Co., LTD.

Company Profile

Sector Bio Diagnostics & Testing